Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Mohler

Showing results (221-230 of 368) with videos related to

Pageof 37
Sort By:
Plos One|December 20, 2016
Unit Nonresponse in a Population-Based Study of Prostate CancerEvrim Oral, Neal Simonsen, Christine Brennan, et al.
Journal of Dairy Science|October 4, 2016
Milk acidification to control the growth of Mycoplasma bovis and Salmonella Dublin in contaminated milkA M Parker, J K House, M S Hazelton, et al.
Plos One|January 25, 2012
Dominant-negative androgen receptor inhibition of intracrine androgen-dependent growth of castration-recurrent prostate cancerMark A Titus, Brian Zeithaml, Boris Kantor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
The androgen axis in recurrent prostate cancerJames L Mohler, Christopher W Gregory, O Harris Ford, et al.
The Journal of Urology|March 29, 2021
Baseline Testosterone Levels in Men with Clinically Localized High-Risk Prostate Cancer Treated with Radical Prostatectomy with or without Neoadjuvant Chemohormonal Therapy (Alliance)James A Eastham, Glenn Heller, David W Hillman, et al.
The Journal of Urology|May 1, 1993
Immunohistochemistry of the androgen receptor in human benign and malignant prostate tissueK K Miyamoto, S A McSherry, G A Dent, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1994
An updated review of the clinical development of coumarin (1,2-benzopyrone) and 7-hydroxycoumarinM E Marshall, J L Mohler, K Edmonds, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 15, 2007
Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylationNupam P Mahajan, Yuanbo Liu, Samarpan Majumder, et al.
Cancer|April 12, 2013
Receipt of National Comprehensive Cancer Network guideline-concordant prostate cancer care among African American and Caucasian American men in North CarolinaShellie D Ellis, Bonny Blackard, William R Carpenter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2021
Cholesterol-Lowering Intervention Decreases mTOR Complex 2 Signaling and Enhances Antitumor ImmunityYanping Wang, Sungyong You, Shengchen Su, et al.
Pageof 37

Showing results (221-230 of 368) with videos related to

Sort By:
Pageof 37
Plos One|December 20, 2016
Unit Nonresponse in a Population-Based Study of Prostate CancerEvrim Oral, Neal Simonsen, Christine Brennan, et al.
Journal of Dairy Science|October 4, 2016
Milk acidification to control the growth of Mycoplasma bovis and Salmonella Dublin in contaminated milkA M Parker, J K House, M S Hazelton, et al.
Plos One|January 25, 2012
Dominant-negative androgen receptor inhibition of intracrine androgen-dependent growth of castration-recurrent prostate cancerMark A Titus, Brian Zeithaml, Boris Kantor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
The androgen axis in recurrent prostate cancerJames L Mohler, Christopher W Gregory, O Harris Ford, et al.
The Journal of Urology|March 29, 2021
Baseline Testosterone Levels in Men with Clinically Localized High-Risk Prostate Cancer Treated with Radical Prostatectomy with or without Neoadjuvant Chemohormonal Therapy (Alliance)James A Eastham, Glenn Heller, David W Hillman, et al.
The Journal of Urology|May 1, 1993
Immunohistochemistry of the androgen receptor in human benign and malignant prostate tissueK K Miyamoto, S A McSherry, G A Dent, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1994
An updated review of the clinical development of coumarin (1,2-benzopyrone) and 7-hydroxycoumarinM E Marshall, J L Mohler, K Edmonds, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 15, 2007
Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylationNupam P Mahajan, Yuanbo Liu, Samarpan Majumder, et al.
Cancer|April 12, 2013
Receipt of National Comprehensive Cancer Network guideline-concordant prostate cancer care among African American and Caucasian American men in North CarolinaShellie D Ellis, Bonny Blackard, William R Carpenter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2021
Cholesterol-Lowering Intervention Decreases mTOR Complex 2 Signaling and Enhances Antitumor ImmunityYanping Wang, Sungyong You, Shengchen Su, et al.
Pageof 37